As the president and CEO of Vir Biotechnology, as well as in his role as head of BIO’s Coronavirus Collaboration Initiative, George Scangos has emerged as a global leader in the fight against COVID-19. In this conversation with Stanford structural biology professor Jody Puglisi, Dr. Scangos explains the challenge of building financially viable therapies for infectious diseases, talks about the current status of COVID-related research, and explores how to build an innovative and meaningful career in biotech.
Related
Hemant Taneja,
General Catalyst
Build, Don’t Break [Entire Talk]
The bigger the impact, the greater the responsibility.
Hemant Taneja,
General Catalyst
Build, Don’t Break [Entire Talk]
The bigger the impact, the greater the responsibility.
Aicha Evans,
Zoox
Driving Innovation [Entire Talk]
Execute bold ideas with conviction.
Aicha Evans,
Zoox
Driving Innovation [Entire Talk]
Execute bold ideas with conviction.
Stephanie Lampkin,
Blendoor
Data-Powered Diversity [Entire Talk]
Data can be a powerful ally in building diverse organizations.
Stephanie Lampkin,
Blendoor
Data-Powered Diversity [Entire Talk]
Data can be a powerful ally in building diverse organizations.
